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Antoine Lavoisier (eighteenth century) dem-
onstrated that living organisms consume 
oxygen to slowly burn the fuels in their bod-
ies to release energy (1). Louis Pasteur (2) in 
an epoch making discovery, recognized as 
“the Pasteur effect,” declared “fermentation is 
an alternate form of life and that fermenta-
tion is suppressed by respiration” [reviewed 
in (3–5)]. Yet another observation of Pasteur, 
that yeast cells consume oxygen to multiply, 
is debated less among cancer biologists. This 
nevertheless, forms the first scientific obser-
vation that proliferating cells need oxygen to 
divide. Pasteur was involved in a path break-
ing debate with Liebig on whether fermenta-
tion is a chemical or a biological process? By 
1880s Pasteur could establish that fermen-
tation is a physiological process, and oxy-
gen, considered to be a putrefying factor by 
Liebig and others, was a growth promoting 
factor [reviewed in (3)]. Six decades later, 
Warburg (6) proposed that damaged respi-
ration and enhanced fermentation of glu-
cose is the prime cause of cancer formation. 
It became popular as “aerobic glycolysis” and 
a counter to “the Pasteur effect.” Warburg was 
uncompromising and was intolerant to any 
alternate theory on cancer formation and 
declared to the German Central Committee 
for Cancer control in 1955 at Stuttgart “… 
there is today no other explanation for the 
origin of cancer cells, either special or gen-
eral. From this point of view, mutation and 
carcinogenic agent are not alternatives, but 
empty words, unless metabolically speci-
fied…” (7). Crabtree (8), a contemporary 
of Warburg, suggested that pathological over 
growths use aerobic glycolysis as a source 
of energy and glucose uptake and glycolytic 
activity has a depressive effect on oxygen 
consumption. His conclusion gained the 
popularity as the “inverted Pasteur effect” 
or the “Crabtree effect” (9). Several authors 
in the middle of twentieth century reported 
that glucose is a negative regulator of respi-
ration. These reports indicate that there is 
an initial stimulation of oxygen consump-
tion for about 20–120 s following glucose 
consumption followed by an inhibitory 
period, which after equilibration stabilizes 
to a constant of about 30% of the endoge-
nous rate until all the glucose was consumed 
[reviewed by (9)].
Pasteur, Warburg, and Crabtree 
– the three edges of a triangle 
Coin?
A critical analysis of the statements suggests 
that Pasteur, Warburg, and Crabtree repre-
sent the three edges of a Triangle Coin, while 
glucose and oxygen form the two sides of the 
coin. Semantics apart, the three authors con-
clude that glucose utilization and the pres-
ence of oxygen are required for proliferating 
cells. Pasteur observed that when sufficient 
oxygen is available, yeast “seizes to be fer-
ment and increases in mass,” but renews its 
capacity to ferment under depleted oxygen. 
His observations that ammonia transformed 
into a complex “albuminoid” (protein) com-
pound during fermentation and growth is 
a recognition of the fact that the two pro-
cesses can coexist when nitrogen source 
and oxygen are available [see the reviews 
(3, 4)]. Warburg’s hypothesis that “dam-
aged respiration promotes fermentation even 
in the presence of oxygen” is a reiteration of 
Pasteur’s statement on growth in principle. 
Warburg considered fermentation but not 
oxygen is a deciding factor in proliferation. 
He was aware that glucose consumption and 
the oxygen levels in different regions of the 
tumors can vary and fermentation decreases 
in the direction of capillary blood flow 
(10). Tumors grafted in low oxygen tension 
were shown to grow slowly (11); Crabtree 
 demonstrated 50% higher respiration in 
subcutaneous tumors than those in abdo-
men which has 50% higher oxygen ten-
sion (8). It is noteworthy that Harvey (12), 
around Warburg’s times, demonstrated that 
oxygen is needed for the proper division of 
Sea Urchin eggs, and lack of oxygen arrests 
the development. Recent studies indicate 
that proliferative cells exhibit altered metab-
olism (13–15) and tumor is a heterogeneous 
tissue; a metabolic symbiosis exists between 
cells in sharing glucose and lactate between 
well oxygenated and low oxygenated popu-
lation of cells (16).
In short, with regard to proliferative 
cells, there are two unifying principles in 
the three apparently diverging hypotheses 
of Pasteur, Warburg, and Crabtree, i.e., 
an inverse relation exists between glucose 
uptake and oxygen utilization (respiration); 
while fermenting cells require more glucose, 
the proliferative cells require both glucose 
and oxygen. Pasteur, in addition, points to 
the requirement of nitrogen as an additional 
source (albuminoid) for growth of yeast
adenylate PhosPhate esters (atP, 
adP, and aMPs) regulate 
MetabolisM
The debate on Warburg and Pasteur, gave a 
lead to deciphering the details of glycolysis, 
citric acid cycle, and the role of adenylate 
phosphate esters (ATP, ADP, and AMPs) 
in metabolic regulation [see (17–21)]. The 
discovery of ATP by Fiske and Subbarow 
and Lohmann paved the way for under-
standing the role of oxygen in ATP gen-
eration through mitochondrial respiration 
and oxidative phosphorylation (OXPHOS) 
[reviewed by (5)]. The debate on the mito-
chondrial function, reactive oxygen  species 
(ROS), and regulation of OXPHOS,  however, 
is still alive (22, 23). Parallel to the research 
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 reprograming (45). One of the consequences 
of inhibition of autophagy is also the inhibi-
tion of mitophagy (46). In addition, inhi-
bition of FoxO3a by activated Akt down 
regulates the anti oxidant enzymes MnSOD 
and catalases (47); mutational deregulation 
of mitochondrial genome by ROS disables 
mitochondrial ability to produce ATP. ROS 
in fact, are suggested to act as rheostat in 
deciding the cell fate and metabolism in 
hematopoietic stem cells by regulating the 
Bcl-2 proteins (48). As already indicated, 
high energy (ATP/ADP) conditions promote 
activation of Akt (43) and the mTOR (44). 
The Akt-mTORC1 signaling also modulates 
the mitochondrial survival by regulating the 
activity of GSK3β, which has crucial regula-
tory role in activation of proapoptotic mito-
chondrial proteins (49, 50). Mitochondria 
are required for amino acid metabolism, 
citrate production, urea production, heme 
synthesis, and FeS assembly etc (51, 52). In 
cancer cells, GSK3β remains inhibited; inhi-
bition of mitophagy during proliferation of 
cells may also lead to activation of aspartate, 
malate, and citrate shuttles, which are very 
much essential for carbon and nitrogen 
recycling during biosynthetic process. The 
life style healthy practices like aerobic exer-
cise, yoga, which promote expenditure of 
energy, the dietary restriction, which limits 
the energy (calorie) intake and therapeutic 
drugs like metformin, PPARγ agonists, which 
promote activation of AMPK and autophagy, 
therefore, play crucial roles in amelioration 
of metabolic pathologies (53, 54).
ConClusion
In summary, it should be recognized that 
there is a unifying concept in the hypoth-
eses of Pasteur, Warburg, and Crabtree that 
proliferative cells require oxygen, nitrogen 
source, and glucose (albeit lesser than that 
required for fermentation). Mitochondria, 
which are central to Warburg’s theory of 
damaged respiration, have diverse func-
tions. Taking cues from signal pathways, it is 
suggested that high ATP/ADP ratio activate 
both Akt and mTORC1, inhibit autophagy/
mitophagy, up regulate ROS, and pro-
mote biosynthetic activity (see Figure 1). 
Mitochondrial metabolism shifts from 
ATP production to anaplerotic reactions 
that replenish fatty acids and non-essential 
amino acids (55) for biosynthesis of mac-
romolecules and membrane structures of 
proliferating cells. During the discussion of 
During biosynthetic processes they act as 
regulators of the metabolic homeostasis in 
cells and regulate the carbon and nitrogen 
fluxes between proteins, lipids by activating 
anaplerotic and cataplerotic reactions for 
reconstruction of membranes, and supra 
molecular structures [see (30–33)].
energy status of Cells also 
Modulates Cell signaling 
PathWays
The explosion of genomic research that fol-
lowed the discovery of DNA double helix in 
the last half of twentieth Century has shifted 
focus of cancer research from metabolism 
to gene mutations (14, 34–36). One of the 
key contributions of the genomic era is 
the discovery of the oncogenes and tumor 
suppressors (37), which work in a regulated 
series of networks of signaling pathways that 
respond to environmental cues in modulat-
ing the energy metabolism and cell cycle 
progression. There was a renewed search for 
pathways responsible for metabolic repro-
graming in cancer cells [see (38–40)] and 
Akt was named as “Warburg enzyme” (41). 
Akt and its downstream target, the mecha-
nistic target of rapamycin (mTOR; earlier 
known as mammalian target of rapamycin), 
were recognized to play crucial role in sev-
eral metabolic disorders including cancer 
[Reviewed by (42)]. The mechanistic tar-
get of rapamycin, especially the complex1 
(mTORC1) plays a crucial role in regulation 
of metabolism and promotes the biosyn-
thetic activity of cells (an energy consuming 
process) and activates cell survival pathways 
by inhibiting GSK3β and autophagy. It has 
come to be recognized that ATP/ADP ratio 
plays critical role in modulating the func-
tions of Akt (43) as well as those of mecha-
nistic target of rapamycin (44).
MitoChondrial dysfunCtion is 
Central to Pathogenesis
Warburg considered dysfunctional mito-
chondria (respiration) as the cause of cancer. 
Generation of superoxide radical (O-
2
) lead-
ing to ROS has become the symbol of mito-
chondrial dysfunction. The key factors that 
promote the ROS generation are high proton 
motive force (∆p), a reduced coenzyme Q 
(CoQ), a high NADH/NAD ratio, and the 
presence of intra mitochondrial O
2
 (22). We 
have earlier presented a view that inhibition 
of autophagy has a crucial role in promot-
ing cell cycle progression and  metabolic 
on cancer cells were the studies on energetics 
of muscle contraction, mainly by Lundsgard, 
Meyerhof, A. V. Hill, and others, where lactate 
production, heat generation, and oxidative 
recovery of the energy remained the main 
focus [reviewed in (4)]. Some of these early 
researchers came out with the theories of 
competitive limitation of inorganic phos-
phates (Pi), ADP, and hexokinase as regu-
lating agents of OXPHOS and glycolysis. Two 
key inhibitors, the indoleacetic acid (IAA) 
and nitrophenols which block glycolysis, 
and OXPHOS respectively, were developed 
to examine the relative influence of glycolysis 
and OXPHOS on metabolism of cells and 
exercising muscles which produced enor-
mous amounts of lactate [reviewed in (4) 
and (24)]. Most of these researchers were 
influenced by either Warburg or Pasteur 
hypotheses. For example, Nigam (25), dem-
onstrated that in Novikoff Ascites-Hepatoma 
cells, when OXPHOS is blocked in the pres-
ence of oxygen by nitrophenols, glucose 
consumption is rapid but reaches a plateau 
within 10–15 min, and glycolysis (lactate 
production) is up regulated at the expense 
of the glycogen synthesis. In the absence of 
nitrophenols glucose up take was propor-
tional to the glycogen synthesis and increased 
slowly but exponentially when compared to 
the cells with blocked OXPHOS. The author 
tried to explain the results as a different type 
of Pasteur effect, but a critical analysis of the 
results indicates that glucose uptake in the 
presence of oxygen is proportional to its util-
ity in macromolecular biosynthesis.
the ratio of aMP and atP (energy 
Charge) regulates glyColysis and 
oXPhos
Phosphofructokinase (PFK) was identi-
fied as a key regulator of glycolysis (4, 26). 
Ramaiah et al. (27) demonstrated that 
the ratio of AMP and ATP in cells decides 
whether PFK is inhibited or activated. 
Atkinson (28) suggested that feed back 
cycles regulate the metabolic fate of cells 
and this regulation depends on the energy 
charge of cells, i.e., [(ATP) + 0.5(ADP)]/
[(ATP) + (ADP) + (AMP)]. The ratio of ATP 
production between glycolysis and mito-
chondrial OXPHOS is 1:15 per one molecule 
of glucose and it takes only few molecules 
of glucose for healthy cells to reach the satu-
rating levels of ADP:ATP ratio of 1:10 (29). 
Mitochondria have several other functions, 
in addition to ATP producing function. 
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Figure 1 | Schematic representation of energy status of cells modulating 
cell signaling and mitochondrial function. Under high energy (ATP/AMP 
ratio)/nutrient levels the insulin/insulin growth factor signaling (IIS) activates 
PI3K-Akt pathway. Initiation of PI3K-Akt signaling takes place when mTORC2 
is active and phosphorylates Akt on Serine473. FoxO is the transcription factor 
of rictor, a critical component of mTORC2. Akt is further phosphorylated at 
Threonine 308 by IIS mediated PIPDK (originally PDK1). High ATP/AMP ratio 
stabilizes the phosphorylations and activated Akt phosphorylates FoxO, which 
leads to its exclusion from the nucleus. Akt inactivates tuberous sclerosis 
complex (TSC) 1/2 resulting in activation of mTORC1. mTORC1 promotes 
biosynthetic activity, inhibits autophagy. When ATP/AMP ratio is high, 
mitochondria stop synthesizing ATP and generate reactive oxygen species 
(ROS) and activate metabolite shuttles to replenish the amino acids and 
citrate, the precursors of protein and membrane lipids. Reduction in the ATP/
ADP ratio, on the other hand, results in activation of AMPK, which activates 
autophagy. FoxO translocates into nucleus transcribes sestrins which inhibit 
mTORC1 and activates mTORC2 by transcribing rictor. The activation of 
glycolysis and glucose transport by Akt S473 and AMPK increases the ATP/
ADP ratio there by reactivating the cycle. Under normal and healthy dietary 
conditions a perfect balance between ATP production, ROS generation, and 
biosynthetic processes is cyclically maintained by activation–inactivation 
cycles of autophagy modulated by alternate activation and inactivation cycle of 
AMPK and mTORC1. Under surplus nutrients/inflammatory conditions, a 
deregulated hyper activated mTORC1 leads to either carcinogenesis or insulin 
resistance. A growing tumor, with increased population of cells is 
heterogeneous with mixed population of cells, either deprived of oxygen or 
having access to it. It maintains a metabolic symbiosis with hypoxic cells 
surviving on glucose uptake and anaerobic glycolysis, while those having 
access to oxygen thrive on lactate accumulating in the neighborhood 
(microenvironment). Akt, protein kinase B (T308, S473 – Phosphorylated sites 
Threonine 308 and Serine 473); AMPK, AMP activated protein kinase; FoxO, 
fork head transcription factors of O group; GSK3β, glycogen synthase 
kinase3β; GLUT, glucose transporter; IGF, insulin growth factor; IRS, insulin 
receptor substrate; mTORC1, 2, mechanistic target of rapamycin Complex 1 
and 2 (mTOR: formerly known as mammalian target of rapamycin); PIP2, 
phosphatidylinositol 4,5 bisphosphate; PIP3, phosphatidylinositol 3,4,5 
trisphosphate; PIPDK, phosphoinositide dependent kinase 1 (the abbreviation 
PIPDK is preferred over the original PDK1 in the article to avoid confusion with 
the pyruvate dehydrogenase kinase, which is also abbreviated as PDK1 in the 
literature); PI3K, Phosphatidylinositol 3-kinases; Rictor, a Component of 
mTORC2; p70S6K, The p70 Ribosomal S6K; ROS, reaction oxygen species; 
Sestrins, stress response proteins.
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